No abstract

Objectives

Both, the LNG-IUS and the GnRH-analogue were effective in the treatment of CPP-associated endometriosis, although no differences were observed between the two treatments. Among the additional advantages of the LNG-IUS is the fact that it does not provoke hypoestrogenism and that it requires only one medical intervention for its introduction every 5 years. This device could therefore become the treatment of choice for CPP-associated endometriosis in women who do not wish to conceive.

Analysis 1.2. Comparison 1 Endometrial injury between day 7 of the previous cycle and day 7 of the ET cycle vs control, Outcome 2 Live birth or ongoing pregnancy per randomly assigned woman (by embryo transfer history).. . Analysis 1.3. Comparison 1 Endometrial injury between day 7 of the previous cycle and day 7 of the ET cycle vs control, Outcome 3 Miscarriage per clinical pregnancy.